High blood pressure is well-known as a threat to heart health. What is less appreciated is how directly it threatens the brain — and not just through stroke. High blood pressure is one of the most significant risk factors for dementia [1].
What makes this particularly concerning is that blood pressure levels once considered safe may still be doing measurable harm, silently raising the risk of cognitive decline over decades.
This article examines the emerging evidence that the traditional blood pressure target of 140 systolic is too high, what the research now recommends as a safer target, and the most effective lifestyle strategies for reaching it.
Table of Contents
Section 1: High BP and Dementia
The connection between high blood pressure and dementia may be surprising, but the clinical evidence for it is substantial. High blood pressure is a recognised modifiable risk factor for dementia — meaning it is something that can be changed, unlike genetic risk. Two large cohort studies illustrate the scale of the relationship clearly.
One cohort study in Hawaii included almost 4,000 men. Scientists checked their blood pressure in middle age and then looked for signs of dementia 20 years later. They found a strong association between midlife blood pressure and dementia in old age. Those with high blood pressure when they were younger had nearly 5 times the risk of dementia compared to those with normal blood pressure [2].
Researchers in Finland found similar results. Once again, people had their blood pressure checked in middle age and were assessed for dementia when older. Those with elevated blood pressure had 2.3 times the risk of dementia later in life [3].
There is even evidence that elevated blood pressure in early adulthood leads to signs of cognitive decline by midlife [4].
So the clinical evidence points to a definite link between blood pressure and dementia. But why does this relationship exist?
The brain requires a large volume of blood to supply energy and oxygen. It is filled with blood vessels, many of which are tiny and sensitive. Elevated blood pressure puts stress on the whole system, causing several problems at once.
It damages blood vessels, increases inflammation, and generates oxidative stress, which accelerates neuron aging. As the body responds to this damage over time, vessels grow stiffer and can form plaques — making the problem progressively worse. With age, the brain gradually loses its ability to adjust to higher pressure and repair the cumulative damage.
This accumulated damage to the brain is a root cause of dementia. The changes are often invisible for years — there are no symptoms until substantial damage has already occurred. By the time cognitive decline becomes apparent, the underlying vascular injury may have been building for a decade or more.
That is why studies often focus on blood pressure measured in midlife. Brain damage from high blood pressure does not happen immediately — the body has mechanisms to temporarily guard the brain against elevated pressure — but over time, significant and irreversible damage can accumulate. Waiting until older age to address blood pressure means accepting a long window of preventable injury.
This is why addressing blood pressure early matters so much. Prevention is far more effective than treatment, and the earlier action is taken, the greater the long-term benefit to brain health.
Section 2: New Targets
This raises a crucial question: when it comes to blood pressure, how high is too high? What level is genuinely safe?
Two groundbreaking studies have fundamentally changed the answer to this question. For decades, medical guidance held that a systolic blood pressure — that is the top number on a blood pressure reading — up to 140 was acceptable. The view was that while 120/80 was ideal, 140 was still within a safe range.
Current evidence shows that view was wrong. A systolic blood pressure near 140 carries real risk — it is not simply a borderline reading.
Part of the reason doctors previously accepted 140 as normal is that blood pressure tends to rise with age, so a modestly higher reading was treated as expected. New research demonstrates that even this modest elevation causes meaningful harm.
The first major wake-up call came from the SPRINT study — the Systolic Blood Pressure Intervention Trial. With over 9,000 participants, the study's findings are difficult to dismiss.
SPRINT compared two groups: one aiming for a systolic blood pressure below 140, and one aiming for below 120. Participants were at high risk for heart disease but did not have diabetes or a prior stroke.
The results were so striking that the study had to be stopped early. After just 3.3 years — against a planned 4–6 year timeline — it was already clear that the lower blood pressure target produced dramatically better outcomes. The group targeting below 120 had a 27% lower risk of heart attack, stroke, or death from cardiovascular causes [5], and a 25% lower risk of death from any cause [6].
A follow-up study in China extended this work to an even larger and more diverse population — over 11,000 people, this time including individuals with diabetes and those who had already experienced a stroke.
The findings were consistent. Lowering systolic blood pressure to below 120 reduced the risk of heart attacks, strokes, and cardiovascular death by 12% [7], and cut the overall risk of death from any cause by 21% over three and a half years [8].
Taken together, both studies point to the same conclusion: the old standard of 140 is no longer adequate. The evidence now points to a systolic target below 120 as the threshold that meaningfully protects cardiovascular health.
Section 3: The New Study
The SPRINT trial and the China study focused primarily on heart attacks, strokes, and all-cause mortality. But what about the brain? Does the same lower blood pressure target also protect against dementia?
A follow-up analysis of the SPRINT study population addressed exactly this question. Researchers examined whether the lower blood pressure target produced the same protective effect for cognitive outcomes. The answer was yes. Participants assigned to the lower target — below 120 systolic — had a 14% lower chance of developing dementia during the follow-up period [9].
A separate study adds further evidence in the same direction. It found that middle-aged women with a systolic blood pressure between 120 and 139 showed increased markers of cognitive decline a decade later. This was not yet clinical dementia, but it indicated measurable brain damage accumulating over time. The researchers concluded that reducing blood pressure below 120 may be necessary to meaningfully reduce the risk of cognitive decline [10].
Together, this body of research makes a compelling case: a systolic target below 120 is not just the right goal for protecting the heart — it is also the right goal for protecting the brain.
Section 4: How to Lower
The evidence is clear on the target. The practical question is how to reach it. The following strategies have the strongest support in the research.
Reduce sodium intake. The American Heart Association recommends a maximum of 1,500 milligrams of sodium per day — roughly half a teaspoon of salt. The average American currently consumes around 3,500 milligrams daily, more than double that amount.
An analysis of 85 trials found a consistent and clear pattern: as sodium intake rises, so does blood pressure [11].
The mechanism is straightforward. Sodium causes the body to retain water, increasing blood volume. Greater fluid in the blood vessels raises the pressure within them — similar to the way a balloon grows tighter as more air is added. Reducing sodium intake is one of the most direct and accessible levers for lowering blood pressure. For those who find it difficult to cut salt outright, a salt substitute can be a practical interim step.
Follow the DASH diet. Researchers have developed an evidence-based dietary framework specifically designed to lower blood pressure: the DASH diet, or Dietary Approach to Stop Hypertension. One analysis reviewing multiple types of blood pressure interventions concluded that the DASH diet may be the most effective non-medication strategy available [12].
The core of the DASH diet is straightforward: emphasise vegetables, fruits, low-fat dairy, whole grains, lean proteins such as chicken and fish, and nuts, while minimising sweets, sugary drinks, and red meat. The pattern is high in fibre, high in lean protein, and nutritionally dense.
One notable benefit of the DASH diet is that it naturally increases potassium intake through foods such as spinach, bananas, peas, and beans. Potassium plays a direct role in blood pressure regulation — it helps balance sodium levels and encourages the walls of blood vessels to relax, which reduces vascular resistance and lowers pressure. Increasing dietary potassium while simultaneously reducing sodium creates a compound effect on blood pressure that exceeds either change alone. This nutrient interaction is part of why the DASH diet outperforms simple salt restriction as a standalone intervention.
Add regular exercise. Physical activity is a consistently effective blood pressure intervention. Both aerobic exercise — such as brisk walking, cycling, or swimming — and resistance training have been shown to reduce systolic blood pressure. The benefits are dose-responsive: more activity generally means greater reductions, though even small increases from a sedentary baseline produce measurable improvements.
For those who find it difficult to carve out dedicated exercise blocks, a practical approach is exercise snacking — short bursts of physical activity distributed throughout the day rather than concentrated into a single session. Instead of a 30-minute gym block, a few sets of wall squats between tasks, a brisk walk during a lunch break, or stair climbing in place of lifts can accumulate into significant cardiovascular benefit. Research supports that these brief bouts are physiologically effective even when they are not consecutive.
Address excess weight. For individuals who are overweight, weight loss is a powerful contributor to blood pressure control. Research shows a clear dose-response relationship: the greater the weight loss, the greater the reduction in blood pressure [13].
Adopting the dietary and exercise strategies above will support weight management alongside blood pressure control. For those whose weight remains above a healthy range despite consistent lifestyle changes, medications such as GLP-1 agonists may be a clinically appropriate addition. Medication in this context is a tool, not a substitute for lifestyle — the two approaches work together.
Consider blood pressure medication when appropriate. For individuals whose lifestyle factors are well-managed and whose weight is healthy, but whose systolic blood pressure still exceeds 120, a clinical discussion about blood pressure medication is warranted. The evidence supports medication as an addition to lifestyle modification — not a replacement for it. The combination of optimised lifestyle and targeted medication offers the most reliable pathway to reaching the below-120 target that research now identifies as protective for both heart and brain.
Reference List
1. https://www.ahajournals.org/doi/10.1161/hyp.0000000000000053
2. https://www.sciencedirect.com/science/article/abs/pii/S0197458000000968?via%3Dihub
3. https://www.bmj.com/content/322/7300/1447
4. https://pubmed.ncbi.nlm.nih.gov/24687777/
5. https://www.nejm.org/doi/10.1056/NEJMoa1901281
6. https://www.nejm.org/doi/10.1056/NEJMoa1901281
7. https://pubmed.ncbi.nlm.nih.gov/38945140/
8. https://pubmed.ncbi.nlm.nih.gov/38945140/
9. https://www.neurology.org/doi/abs/10.1212/WNL.0000000000213334
10. https://pubmed.ncbi.nlm.nih.gov/25814553/
11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055199/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7792371/
13. https://www.uptodate.com/contents/image?imageKey=NEPH%2F60178&topicKey=PC%2F3852&source=see_link
